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Summary.-Various facts are now known about the relative lymphoma resistance
of a group of tetraparental AKR - CBA/H-T6 chimaeras derived by early embryo
aggregation. Firstly, their tumour resistance is not due to the lackofthe lymphoma-
prone AKR cells. Secondly, results showing titres of MuLV-gs antigen comparable
with, and occasionally in excess of, those in the AKR suggest that the tumour re-
sistance of the chimaeras is unlikely to be due to a lack of oncogenic leukaemia
virus.
However, in marked contrast to the AKR, antibody-viral antigen renal complexes
in the chimaeras were minimal. Lack of viral antigens could not explain the relative
lack of renal complexes. Absence of the corresponding anti-viral antibody is
the most likely explanation and this has to be attributed to the CBA component
of the tetraparental AKR - CBA/H-T6 chimaeras. We suggest that with tolerance
to the leukaemia virus being maintained and in the absence of anti-viral antigenic
complexes, tumour-specific sites can be recognized and thus tumours are eliminated.
This hypothesis remains to be proven.
THE AKR strain of mice is charac-
terized by the spontaneous development
of Gross virus-associated lymphomata.
Although the incidence varies between
sublines (Acton et al., 1973), the AKR/J
investigated here was earlier noted to
have a 100% incidence of lymphomata
by the age of 56 weeks (Barnes, Tuffrey
and Kingman, 1972a). In contrast, the
CBA/H-T6 is relatively resistant to lym-
phomata (Murphy, 1966). To study the
interaction between factors leading to
lymphomata in the AKR and those
associated with lymphoma resistance in
the CBA, AKR - CBA/H-T6 tetraparen-
tal mouse chimaeras derived by early
embryo aggregation were investigated.
The mode of derivation (Barnes et
al., 1972b) and the relative lymphoma
resistance of the AKR - CBA/H-T6 chi-
maeras has been noted earlier: out of
18 AKR - CBA/H-T6 chimaeras, tu-
mours were not detected in the remaining
12 mice, which generally remained well
and on occasions lived up to more than
three times the average life span of the
AKR (Barnes et al., 1973). One possible
explanation for the tumour resistance in
the AKR < CBA/H-T6 chimaeras was
the loss of the lymphoma-prone AKR
cell population. Tetraparental chimaeras
vary in composition (Mintz and Palm,
1969) and, furthermore, changes in the
two parental cell populations occur during
life (Barnes et al., 1972b). This occasion-
ally leads to the loss of one or other
parental cell population (Barnes et al.,
1972b), but this did not explain the
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tumour resistance of the AKR " CBA/H-
T6 chimaeras. Cytogenetic analysis of
phytohaemagglutinin (PHA)-stimulated
peripheral blood cultures in fact showed
an overwhelming preponderance (>99%0)
of AKR cells in the AKR CBA/H-T6
chimaeras (Tuffrey et al., 1973). This
phenomenon was not confined to PHA-
stimulated peripheral blood cultures, since
an overwhelming preponderance of AKR
mitoses was also seen in direct unstim-
ulated preparations of both the lympho-
myeloid complex (thymus, spleen, bone
marrow and Peyer's patches (>90%0)
and also in the somatic tissues including
relatively avascular structures such as
the cornea (>80%) (Ford et al., 1975).
Although this phenomenon remains
unexplained, tumour resistance of the
chimaeras could not be attributed to
the absence of lymphoma-prone AKR
cells.
Gross clearly established the causal
role of a subcellular transmissible agent
in the lymphoma of the AKR (Gross,
1951). Conceivably, therefore, tumour
resistance of the AKR <-> CBA/H-T6 chi-
maeras may have been due to the loss
of this oncogenic agent. Although large
numbers of type-C murine leukaemia
virus-like particles were identified in
each chimaera (Wills, Tuffrey and Barnes,
1975), we have here sought to confirm
their MuLV-gs antigenic specificity using
an immunofluorescence absorptioin tech-
niique (Hilgers et al., 1974). Immuno-
fluorescence was also used to investigate
the extent of antibody-antigen complexes
in the renal glomeruli of the chimaeras.
MATERIALS AND METHODS
Two tests used together formed the
basis for MuLV-gs screening and both tests
have been described in detail earlier (Hilgers
et al., 1974). Firstly, an indirect immuno-
fluorescence test (IF) was used to titrate
the activity of the specific MuLV-gs antisera
against acetone-fixed AKR lymphoma cells.
The anti-MuLV-gs sera were prepared in
a goat by Dr R. Gilden using an isoelectrically
purified gs antigen. Doubling dilutions of
the anti-MuLV-gs sera were prepared and
these were subsequently applied to lymphoma
cells fixed upon glass slides. After washing,
the slides were treated with fluorescein-
labelled rabbit anti-goat IgG at a previously
determined optimum dilution. Thus the
titre of the anti-MuLV-gs sera was deter-
mined according to previously described
criteria (Hilgers et al., 1974). Following
titration, the anti-MuLV-gs antisera were
used in the immunofluorescence absorption
technique (IFA). In practice this was used
at twvo dilutions greater than the previously
determined end-point and the effect of
mouse sera and tissue absorption examined.
Sera were obtained at intervals from both
the chimaeras and AKR and CBA controls.
These were subsequently stored at -35°C
until used for absorption. Absorption was
also carried out oni tissue obtained at sacrifice
and these snap-frozen in isopentane in an
equilibrated isopentane-solid-Co2 mixture.
These were subsequently stored in isopentane
at -70°C prior to use. The tissues were
eventually homogenized and after centrifuga-
tion an aliquot of the supernatant was
used for absorption of the antisera according
to the technique described previously (Hilgers
et al., 1974). Doubling dilutions of the
supernatant from the tissues (" Soluble
antigen ") were incubated (4°C overnight)
with an equivalent volume of the diluted
antisera. Dilutions of the chiniaera sera
were also treated in a similar fashion. In
both cases the absorbed antiserum was
then used in the indirect IF test and its
end-point again determined. The antigen
titre w-as expressed as the dilution of the
corresponding dilution of the antiserum that
absorbed out the antigen, e.g. an antigen
titre of 1/1 refers to the absorption by an
amount of MuLVl-gs antigen contained in
neat serum or tissue supernatant, whereas
an antigen titre of 1/4 refers to successful
absorption by a 1:4 dilution, and so on.
Three fluorescein-labelled antisera were
used " directly " in assessing the staining
of the renal antibody-antigen complex. In
each case coded unfixed cryostat-cut renal
sections were examined. CBA-anti-AKR
and AKR-anti-CBA allotype antisera were
conjugated with fluorescein isothiocyanate
according to the technique described else-
where (Barnes, Holliday and Tuffrey, 1974a)
and were used, together with a commercially
obtained heterologous anti-mouse Ig fluo-
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rescein-labelled antiserum (GAM/Ig-FITC;
Nordic Laboratories) to assess the extent
of renal complex staining.
RESULTS
The distributions of MuLV-gs antigen
in the chimaeras and the controls are
shown in the Table. Certain of the
control data have been presented pre-
viously (Hilgers et al., 1974). From
these results it is clear that MuLV-gs
antigen was present in the tissues of all
the chimaeras and furthermore in com-
parable amounts to the parental AKR.
Not only were the titres of antigen in
the chimaeras comparable with the AKR,
but also the distribution of the antigen
was very similar to a pre-leukaemic
AKR. As can be seen from the results in
the Table, in spite of large quantities
of gs-antigen in the tissues and the sera,
there was very little antibody-antigen
renal complex staining seen in any of
the chimaeras (Fig. 1). This contrasted
with the findings in the AKR, where
there was marked renal complex staining
(Fig. 2).
The fact that the minimal renal
staining in the chimaeras was generally
of AKR allotype specificity (Table), al-
though not surprising, since the AKR
allotype predominated in the serum
(Barnes et al., 1974b), has to be considered
in respect ofthe fact that the antisera were
not necessarily specific. The AKR, un-
like the CBA, is deficient in C'5 and
its associated antigen MuBl (Cinader,
Dubiski and Wardlaw, 1964). It there-
fore seems likely that the AKR-anti-
CBA allotype sera also had anti-MuBI
(C') reactivity and this may have con-
tributed to the renal staining.
DISCUSSION
It is well known that the CBA mice
are relatively resistant to the development
of lymphomata (Murphy, 1966). Even
if transplanted at the early blastocyst
stage and born from AKR, the CBA
remain resistant to lymphomata (Barnes
and Tuffrey, 1974a). In contrast, AKR
transplanted and born from the CBA
develop lymphomata (Barnes and Tuffrey,
1974b), arguing that the "cause" of
Frto.1. M-Minimal soluble antibody-antigen complex glomerular staining in tetraparental
AKR +-4 CBA/H-T6 chimaeras: anti-mouse Ig-FITC conjtugate. x 1150.
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FIG. 2. Marked soluble antibody-antigen complex glomerular staining in age(I AKR:
anti-mouse Ig-FITC conjugate. x 1150.
the disease in the AKR is established
prior to the stage of implantation. Be-
cause of this it is anticipated that the
" cause " of the disease is present in the
AKR - CBA/H-T6 chimaeras, since these
were constructed by aggregation of early
embryos. In view of the relative tumour
resistance of these chimaeras it appears
important to compare the two parental
strains in respect of murine tumour
genetics.
Lilly (1966) first established that the
major H-2 histocompatibility locus in
the mouse was associated with resistance
and susceptibility to Gross-induced leuk-
aemia. Since H-2k is related to virus-
associated tumour susceptibility, it is
not surprising to find that the AKR
is H-2k. But this is also true for the
CBA/H-T6, now known as CBA/H-
T6 Crc, which has also recently been
confirmed by Dr D. A. L. Davies as
H-2k. In spite of being H-2k the CBA
remain resistant to tumours. In this
respect one might have anticipated that
H-2k AKR > H-2k CBA chimaeras may
have been susceptible to virus-associated
tumours, but this was not the case (Barnes
et al., 1973). One was therefore led to
question the situation with regard to
the primary susceptibility to virus infec-
tion rather than the secondary effect of
tumour induction.
MuLV expression is also under genetic
control. As at the H-2 locus the AKR
and CBA are both Fv-1n and conse-
quently permissive to N-tropic (e.g. Gross)
virus infection (Rowe, 1972; Rowe and
Hartley, 1972; Hilgers and Galesloot,
1973). In this respect, if the CBA were
Fv-lb (which they are not) then one
would have anticipated interference with
viral expression. This obviously was not
the case. The numerous C-type particles
seen in electron microscopy (Wills et
al., 1975) and the high titres of viral
antigen noted here are compatible with
an AKR Fv-1"Fv-ln CBA situation
(doubly) permissive to N-tropic virus
infection.
Oldstone and his colleagues were the
first to comment on the marked soluble
antigen-antibody complex renal staining
seen in AKR (Oldstone, Aoki and Dixon,
1972). In contrast, renal complexes were
minimal in the AKR - CBA chimaeras.
This was a remarkable observation in
many respects. Firstly, there chimaerasMURINE LEUKAEMIA VIRUS GROUP-SPECIFIC ANTIGEN 33
appeare(I to be predominantly AKR in
cellular composition (Tuffrey et al., 1973;
Ford et al., 1975) and therefore the lack
of complexes had to be attributed to
the influence of a relatively minor CBA
cell component. The fact that levels
of MuLV antigen were comparable with
the AKR ruled out the possibility that
the lack of complexes was due to the
lack of viral antigen. Lack of cor-
responding AKR antibody initially also
appeared an unlikely explanation, since
analysis of the genetically determined
allotype antibody also showed a general
AKR predominance (Barnes et al., 1974b).
In spite of this, however, absence of
the corresponding anti-MuLV antibody
seems the most likely explanation for
the relative lack of renal complexes in
the chimaeras (Barnes, Tuffrey and Holli-
day, 1975; Barnes, Tuffrey and Bourne,
1975). Whether absence of anti-viral
antibody plays any role in the relative
tumour resistance of the chimaeras, how-
ever, remains to be determined. but
evidence points to clear differences in
the immune response of the two strains.
In spite of being acquired early in
embryonic life, tolerance to the oncongenic
virus is short-lived in the AKR. Anti-
viral antibodies are detected from about
the age of 3 months and these are held
in part responsible for the soluble antigen-
antibody renal complexes observed in
the AKR (Oldstone et al., 1972). Absence
of suchi complexes in the chimaeras has
to be attributed to the relatively minor
CBA component. Similarly, the tumour
resistance of the chimaeras has to be
attributed to the CBA component. The
question remains whether the immune
response controlling (Jr) genes, and factors
controlling tumour resistance are identical.
This remains to be determined.
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